Article
Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.
Brain pathology (Zurich, Switzerland) - 1 Jul 2013
Appin Christina L, Gao Jingjing, Chisolm Candace, Torian Mike, Alexis Dianne, Vincentelli Cristina, Schniederjan Matthew J, Hadjipanayis Costas, Olson Jeffrey J, Hunter Stephen, Hao Chunhai, Brat Daniel J
Abstract excerpt
Glioblastoma (GBM) is an aggressive primary brain tumor with an average survival of approximately 1 year. A recently recognized subtype, glioblastoma with oligodendroglioma component (GBM-O), was designated by the World Health Organization (WHO) in 2007. We investigated GBM-Os for their clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
